A Day Up For Evelo Biosciences, Inc.
Mon, Apr 12, 2021 at 05:30 PM
Evelo Biosciences, Inc. (EVLO:NASDAQ) soared at $11.82, representing a gain of 17.7%. On Fri, Apr 09, 2021, EVLO:NASDAQ hit a New 2-Week Intraday Low of $9.62. The stock got featured on our News Catalysts scanner on Mon, Apr 05, 2021 at 07:33 AM in the 'MISCELLANEOUS' category. From Fri, Mar 26, 2021, the stock recorded 33.33% Up Days and 20.00% Green Days
The share price of the company has been moving sideways in recent weeks.
About Evelo Biosciences, Inc. (EVLO:NASDAQ)
Evelo Biosciences Inc operates as a bio-technology company. The firm develops therapies for the treatment of the gut-body network. Evelo Biosciences also offers treatment for cancer and inflammatory diseases.
Top 10 Gainers:
- Celcuity Inc. (CELC:NASDAQ), 29.35%
- LHDX (LHDX:NASDAQ), 27.01%
- Wilhelmina International, Inc. (WHLM:NASDAQ), 25.18%
- Lineage Cell Therapeutics, Inc. (BTX:NYSEMKT), 23.02%
- ATNF (ATNF:NASDAQ), 23%
- PLBY (PLBY:NASDAQ), 19.89%
- Pintec Technology Holdings Limited (PT:NASDAQ), 18.03%
- TSHA (TSHA:NASDAQ), 17.98%
- Tiziana Life Sciences PLC (TLSA:NASDAQ), 17.98%
- Evelo Biosciences, Inc. (EVLO:NASDAQ), 17.73%